Empagliflozin and Assessment of Lower-Limb Amputations in the EMPA-REG OUTCOME Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Empagliflozin and Assessment of Lower-Limb Amputations in the EMPA-REG OUTCOME Trial

Published:2017-11-13 Issue:1 Volume:41 Page:e4-e5
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Inzucchi Silvio E.¹,Iliev Hristo²^ORCID,Pfarr Egon²,Zinman Bernard³

Affiliation:

1. Section of Endocrinology, Yale School of Medicine, New Haven, CT

2. Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany

3. Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, and Division of Endocrinology and Metabolism, University of Toronto, Toronto, Canada

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/41/1/e4/553734/dc171551.pdf

Reference4 articles.

1. Canagliflozin and cardiovascular and renal events in type 2 diabetes;Neal;N Engl J Med,2017

2. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes;Zinman;N Engl J Med,2015

3. Safety and tolerability of empagliflozin in patients with type 2 diabetes: pooled analysis of phase I-III clinical trials;Kohler;Adv Ther,2017

4. Microvascular complications and foot care. Sec. 10. In Standards of Medical Care in Diabetes—2017;American Diabetes Association;Diabetes Care,2017

Cited by 341 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Newer Outpatient Diabetes Therapies and Technologies;Medical Clinics of North America;2024-09

2. Treatment with sodium‐glucose cotransporter 2 inhibitors and risk of lower‐limb amputations;Diabetes, Obesity and Metabolism;2024-07-11

3. Challenges and opportunities in the management of type 2 diabetes in patients with lower extremity peripheral artery disease: a tailored diagnosis and treatment review;Cardiovascular Diabetology;2024-06-26

4. Safety of Empagliflozin: An Individual Participant-Level Data Meta-Analysis from Four Large Trials;Advances in Therapy;2024-05-21

5. Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Hospitalization for Heart Failure and Amputation Rate Compared With Incretin-Based Therapy in Patients With Diabetic Foot Disease: A Nationwide Population-Based Study;Endocrine Practice;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3